Sanofi (SNYNF) Change in Accured Expenses (2020 - 2021)
Sanofi (SNYNF) posted Change in Accured Expenses of -$2.5 million for Q4 2021, up 53.09% sequentially from -$5.4 million in Q4 2020, and up 53.09% YoY from -$1.6 million in Q4 2020.
Sanofi (SNYNF) Change in Accured Expenses (2020 - 2021) Analysis & Trends
Sanofi (SNYNF) has 2 years of Change in Accured Expenses data on file, last reported at -$2.5 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | -629.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -1.59 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -75.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | -702.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -2.52 Mn |
| Dec 31, 2021 | -2.52 Mn |
| Dec 31, 2020 | -5.37 Mn |
| Dec 31, 2020 | -5.37 Mn |